🇺🇸 FDA
Pipeline program

Aflibercept

15-442

Approved small_molecule active

Quick answer

Aflibercept for Retinal Vein Occlusion is a Approved program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Retinal Vein Occlusion
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials